CBOE.org Home | CBOE.com| CBSX Site | CFE Site | Contact CBOE      
CBOE - Hybrid Home
Features
Hybrid 2.0
HyTS Terminal
Hybrid Connectivity
Independent Software Vendors
Penny Pilot Program
Hybrid News
Hybrid Contact Us

CBOE Hybrid®, The Hybrid Trading System
Independent Software Vendors


PRIME Analytics LLC is a financial software firm that develops systems for trading professionals in the derivatives industry. The firm is based in Chicago, with offices in Tucson, New York, and London. The goal of PRIME Analytics since its' inception has been to develop, market, and support the most comprehensive, sophisticated and integrated derivatives trading and risk management platform in the professional trading community.

ProOpticusTM is PRIME Analytics' solution for connecting the trading professional to the global marketplace. It is a complete trading package, offering option valuation, trade execution, and risk management solutions across a wide variety of instruments for traders, brokers, and risk managers in both open outcry and electronic markets. Integrating a state of the art front-end trading application with a variety of risk management tools allows complete flexibility to research, trade, and manage risk in any type of situation.

We welcome you to explore and compare ProOpticus' features to any of our competitors. We believe that, regardless of what area of the trading industry you are in, PRIME Analytics has the complete solution for the trading professional in the ProOpticusTMSystem.

Contact: Joe Campbell
Telephone: 312-650-7021
Email: jcampbell@prime-analytics.com
Options involve risk and are not suitable for all investors. Prior to buying or selling an option, a person must receive a copy of Characteristics and Risks of Standardized Options (ODD). Copies of the ODD are available from your broker, by calling 1-888-OPTIONS, or from The Options Clearing Corporation, One North Wacker Drive, Suite 500, Chicago, Illinois 60606. The information on this website is provided solely for general education and information purposes and therefore should not be considered complete, precise, or current. Many of the matters discussed are subject to detailed rules, regulations, and statutory provisions which should be referred to for additional detail and are subject to changes that may not be reflected in the website information. No statement within the website should be construed as a recommendation to buy or sell a security or to provide investment advice. The inclusion of non-CBOE advertisements on the website should not be construed as an endorsement or an indication of the value of any product, service, or website. The Terms and Conditions govern use of this website and use of this website will be deemed acceptance of those Terms and Conditions.